2022
DOI: 10.1016/j.jddst.2022.103269
|View full text |Cite
|
Sign up to set email alerts
|

Baicalin as an emerging magical nutraceutical molecule: Emphasis on pharmacological properties and advances in pharmaceutical delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 135 publications
0
5
0
Order By: Relevance
“…The cellulose‐based dialysis membrane bag used in the drug‐releasing test is known to allow the free passage of test substances with molecular weights 12 to 70 times smaller than MWCO [49] . Previous studies have reported that polymers can be used to modulate the particle size or zeta potential of drugs containing baicalin or berberine, resulting in prolonged effects with delayed release or quick effects with rapid release [50,51] . Chrysin 6A8G and palmatine are suggested to be associated with polymers that are sized to permeate dialysis membranes, thereby enhancing their release.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The cellulose‐based dialysis membrane bag used in the drug‐releasing test is known to allow the free passage of test substances with molecular weights 12 to 70 times smaller than MWCO [49] . Previous studies have reported that polymers can be used to modulate the particle size or zeta potential of drugs containing baicalin or berberine, resulting in prolonged effects with delayed release or quick effects with rapid release [50,51] . Chrysin 6A8G and palmatine are suggested to be associated with polymers that are sized to permeate dialysis membranes, thereby enhancing their release.…”
Section: Resultsmentioning
confidence: 99%
“…[49] Previous studies have reported that polymers can be used to modulate the particle size or zeta potential of drugs containing baicalin or berberine, resulting in prolonged effects with delayed release or quick effects with rapid release. [50,51] Chrysin 6A8G and palmatine are suggested to be associated with polymers that are sized to permeate dialysis membranes, thereby enhancing their release. Conversely, baicalin, magnoflorine, columbamine, berberine, and coptisine interacted with the polymer and precipitated to a size that was not permeable to the dialysis membrane.…”
Section: In-vitro Drug Release Studiesmentioning
confidence: 99%
“…Moreover, baicalin is commonly used as adjuvant therapy for hepatitis. In a clinical study, single dose baicalin (500 mg/kg) in combination with cyclosporin A was found to be safe and well tolerated in adult human subjects without any severe adverse effects[ 125 ]. However, the co-administration of baicalin with other herbal formulations or drugs might impede baicalin’s in vivo actions and consequently its efficacy.…”
Section: Drug Delivery Clinical Trial and Future Prospectsmentioning
confidence: 99%
“…The main flavonoid of Scutellaria baicalensis is baicalin (its concentration in the roots of the plant reaches from 8.1% to 15.6% [30,31]). Baicalin (7-glucuronic acid, 5,6-dihydroxy-flavone) is a flavonoid compound [36] capable of inhibiting enzymes and regulating the immune response [37,38], exhibiting antitumor, antimicrobial, anti-inflammatory, neuroprotective, antidiabetic, antimutagenic, anticonvulsant, and antioxidant properties [39][40][41]. There are studies in which it has been proven that this flavonoid exhibits antibacterial activity against H. pylori [42]: by Baicalin (7-glucuronic acid, 5,6-dihydroxy-flavone) is a flavonoid compound [36] capable of inhibiting enzymes and regulating the immune response [37,38], exhibiting antitumor, antimicrobial, anti-inflammatory, neuroprotective, antidiabetic, antimutagenic, anticonvulsant, and antioxidant properties [39][40][41].…”
Section: Introductionmentioning
confidence: 99%
“…Baicalin (7-glucuronic acid, 5,6-dihydroxy-flavone) is a flavonoid compound [36] capable of inhibiting enzymes and regulating the immune response [37,38], exhibiting antitumor, antimicrobial, anti-inflammatory, neuroprotective, antidiabetic, antimutagenic, anticonvulsant, and antioxidant properties [39][40][41]. There are studies in which it has been proven that this flavonoid exhibits antibacterial activity against H. pylori [42]: by Baicalin (7-glucuronic acid, 5,6-dihydroxy-flavone) is a flavonoid compound [36] capable of inhibiting enzymes and regulating the immune response [37,38], exhibiting antitumor, antimicrobial, anti-inflammatory, neuroprotective, antidiabetic, antimutagenic, anticonvulsant, and antioxidant properties [39][40][41]. There are studies in which it has been proven that this flavonoid exhibits antibacterial activity against H. pylori [42]: by suppressing the expression of hefA genes (a gene affecting the multidrug resistance of H. pylori) and vacA (a gene that affects the production of exotoxin and promotes bacterial adhesion on stomach cells, leading to vacuolization of the cytoplasm of the target cell, its apoptosis, and death), and by inhibiting the action of urease and increasing the sensitivity of H. pylori strains to the action of amoxicillin and tetracycline [43][44][45].…”
Section: Introductionmentioning
confidence: 99%